Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats

Pharmacology Biochemistry and Behavior

Volumn 79, Issue 2, 2004, Pages 331-342

  Morley, Kirsten C ^a   Cornish, Jennifer L ^a   Li, Kong M ^b   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Acquisition; Amphetamine; Ecstasy; Extinction; Maintenance; MDMA; Neurotoxicity; Reinstatement; Self administration; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE; MONOAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELF ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEXTROAMPHETAMINE; DRUG INTERACTIONS; EXTINCTION, PSYCHOLOGICAL; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; SELF ADMINISTRATION; SEROTONIN; SEROTONIN AGENTS; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 11144271460     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.08.004     Document Type: Article

References (91)

1. C. Achat-Mendes, K.L. Anderson, and Y. Itzhak Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood Neuropharmacology 45 2003 106 115
2. L.A. Badon, A. Hicks, K. Lord, B.A. Ogden, S. Meleg-Smith, and K.J. Varner Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy J. Pharmacol. Exp. Ther. 302 2002 898 907
3. L.E. Baker, and M.M. Taylor Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination Pharmacol. Biochem. Behav. 57 1997 737 748
4. L.E. Baker, E.K. Broadbent, E.K. Michael, P.K. Mathews, C.A. Metosh, and R.B. Saunders Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA) Behav. Pharmacol. 6 1995 263 275
5. E.J. Bilsky, Y. Hui, C.L. Hubbell, and L.D. Reid Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage Pharmacol. Biochem. Behav. 37 1990 633 638
6. D. Braida, and M. Sala Role of the endocannabinoid system in MDMA intracerebral self-administration in rats Br. J. Pharmacol. 136 2002 1089 1092
7. H.W. Broening, J.F. Bowyer, and W. Slikker Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response J. Pharmacol. Exp. Ther. 275 1995 325 333
8. E.J. Bull, P.H. Hutson, and K.C.F. Fone Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT(2C) receptor responsivity Neuropharmacology 44 2003 439 448
9. T. Byrne, L.E. Baker, and A. Poling MDMA and learning: effects of acute and neurotoxic exposure in the rat Pharmacol. Biochem. Behav. 66 2000 501 508
10. C.W. Callaway, and M.A. Geyer Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist J. Pharmacol. Exp. Ther. 263 1992 318 326
11. C.W. Callaway, L.L. Wing, and M.A. Geyer Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats J. Pharmacol. Exp. Ther. 254 1990 456 464
12. C.W. Callaway, N. Rempel, R.Y. Peng, and M.A. Geyer Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4- methylenedioxymethamphetamine Neuropsychopharmacology 5 1992 113 127
13. R.M. Carelli, S.G. Ijames, and A.J. Crumling Evidence that separate neural circuits in the nucleus accumbens encode cocaine versus 'natural' (water and food) reward J. Neurosci. 20 2000 4255 4266
14. K.J. Clemens, P.S. van Nieuwenhuyzen, K.M. Li, J.L. Cornish, G.E. Hunt, and I.S. McGregor MDMA ("Ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat Psychopharmacology 178 2004 318 325
15. J.C. Cole, H.R. Sumnall, E. O'Shea, and H.M. Marston Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse Psychopharmacology (Berl.) 166 2003 383 390
16. J.L. Cornish, Z. Shahnawaz, M.R. Thompson, S. Wong, K.C. Morley, and G.E. Hunt Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats Eur. J. Pharmacol. 482 2003 339 341
17. H. de Wit, and J. Stewart Reinstatement of cocaine-reinforced responding in the rat Psychopharmacology (Berl.) 75 1981 134 143
18. A. Ettenberg Haloperidol prevents the reinstatement of amphetamine-rewarded runway responding in rats Pharmacol. Biochem. Behav. 36 1990 635 638
19. P.J. Fletcher Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine Psychopharmacology (Berl.) 118 1995 155 163
20. P.J. Fletcher, K.M. Korth, and J.W. Chambers Selective destruction of brain serotonin neurons by 5,7-dihydroytryptamine increases responding for a conditioned reward Psychopharmacology (Berl.) 1999 291 299
21. P.J. Fletcher, S.R. Robinson, and D.L. Slippoy Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats Neuropsychopharmacology 25 2001 195 203
22. P.J. Fletcher, A. Azampanah, and K.M. Korth Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule Pharmacol. Biochem. Behav. 71 2002 717 725
23. P.J. Fletcher, A.J. Grottick, and G.A. Higgins Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding Neuropsychopharmacology 27 2002 576 586
24. P.J. Fletcher, K.M. Korth, S.R. Robinson, and G.B. Baker Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement Psychopharmacology (Berl.) 162 2002 282 291
25. K.C.F. Fone, S.R.G. Beckett, I.A. Topham, J. Swettenham, M. Ball, and L. Maddocks Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity Psychopharmacology (Berl.) 159 2002 437 444
26. G.J. Gerber, and R. Stretch Drug-induced reinstatement of extinguished self-administration behavior in monkeys Pharmacol. Biochem. Behav. 3 1975 1055 1061
27. R.A. Glennon, and R. Young Further investigation of the discriminative stimulus properties of MDA Pharmacol. Biochem. Behav. 20 1984 501 505
28. A.K. Goodwin, and L.E. Baker A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats Exp. Clin. Psychopharmacol. 8 2000 415 423
29. A.K. Goodwin, D.M. Pynnonen, and L.E. Baker Serotonergic-dopaminergic of MDMA's discriminative stimulus effects in a three-choice discrimination Pharmacol. Biochem. Behav. 74 2003 987 995
30. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") Pharmacol. Rev. 55 2003 463 508
31. G.A. Gudelsky, and J.F. Nash Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions J. Neurochem. 66 1996 243 249
32. C.G. Gurtman, K.C. Morley, K.M. Li, G.E. Hunt, and I.S. McGregor Increased anxiety in rats after 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"): association with serotonin depletion Eur. J. Pharmacol. 446 2002 89 96
33. A. Harkin, T.J. Connor, J. Mulrooney, J.P. Kelly, and B.E. Leonard Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats Life Sci. 68 2001 1367 1382
34. A.A. Harrison, and A. Markou Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors J. Pharmacol. Exp. Ther. 297 2001 316 325
35. A.S. Hollister, G.R. Breese, C.M. Kuhn, B.R. Cooper, and S.M. Schanberg An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine J. Pharmacol. Exp. Ther. 198 1976 12 22
36. B. Horan, E.L. Gardner, and C.R.J. Ashby Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA) Synapse 2000 35
37. C.B. Hubner, M. Bird, S. Rassnick, and C. Kornetsky The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward Psychopharmacology (Berl.) 95 1988 49 51
38. Y. Itzhak, S.F. Ali, C.N. Achat, and K.L. Anderson Relevance of MDMA ('ecstasy')-induced neurotoxicity to long-lasting psychomotor sensitization in mice Psychopharmacology 166 2003 241 249
39. L. Johnston, P. O'Malley, and J. Bachman Monitoring the future: drug trends in 1999-2000 among American teens 2000 University of Michigan Lansing, MI
40. P.W. Kalivas, P. Duffy, and S.R. White MDMA elicits behavioral and neurochemical sensitization in rats Neuropsychopharmacology 18 1998 469 479
41. M.D. Kelland, and L.A. Chiodo Serotonergic modulation of midbrain dopamine systems 1996 CRC Press Boca Raton, FL
42. P.H. Kelly, and S.D. Iversen Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur. J. Pharmacol. 40 1976 45 56
43. M.J. Landry MDMA: a review of epidemiologic data J. Psychoactive Drugs 34 2002 163 169
44. H.Q. Lin, D.M. Jackson, D.M. Atrens, M.J. Christie, and I.S. McGregor Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation Brain Res. 744 1997 351 357
45. E.A. Loh, and D.C. Roberts Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin Psychopharmacology (Berl.) 101 1990 262 266
46. W.H. Lyness, N.M. Friedle, and K.E. Moore Destruction of dopaminergic nerve terminals in nucleus accumbens: effects on d-amphetamine self-administration Pharmacol. Biochem. Behav. 11 1979 553 556
47. H.M. Marston, M.E. Reid, J.A. Lawrence, H.J. Olverman, and S.P. Butcher Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat Psychopharmacology (Berl.) 144 1999 67 76
48. L. Matuszewich, M.E. Filon, D.A. Finn, and B.K. Yamamoto Altered forebrain neurotransmission responses to immobilization stress following 3,4-methylenedioxymethamphetamine Neuroscience 110 2002 41 48
49. I.S. McGregor Using Strawberry Tree WorkbenchMac and Workbench PC software for data acquisition and control in the animal learning laboratory Behav. Res. Methods Instrum. Comput. 28 1996 38 48
50. I.S. McGregor, K.J. Clemens, G. Van Der Plasse, K.M. Li, G.E. Hunt, and F. Chen Increased anxiety 3 months after brief exposure to MDMA ('Ecstasy') in rats: association with altered 5-HT transporter and receptor density Neuropsychopharmacology 28 2003 1472 1484
51. I.S. McGregor, C.G. Gurtman, K.C. Morley, K.J. Clemens, A. Blokland, and K.M. Li Increased anxiety and "depressive" symptoms months after MDMA ("Ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes Psychopharmacology (Berl.) 168 2003 465 474
52. M.J. Morgan Ecstasy (MDMA): a review of its possible persistent psychological effects Psychopharmacology (Berl.) 152 2000 230 248
53. M.J. Morgan, B. Horan, S.L. Dewey, and C.R.J. Ashby Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study Eur. J. Pharmacol. 331 1997 R1 R3
54. K.C. Morley, J.E. Gallate, G.E. Hunt, P.E. Mallet, and I.S. McGregor Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("Ecstasy") Eur. J. Pharmacol. 433 2001 91 99
55. K.C. Morley, K.M. Li, G.E. Hunt, P.E. Mallet, and I.S. McGregor Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("ecstasy") in rats Neuropharmacology 46 2004 954 965
56. R. Oberlender, and D.E. Nichols Drug discrimination studies with MDMA and amphetamine Psychopharmacology (Berl.) 95 1998 71 76
57. E.D. O'Loinsigh, J.P. Kelly, and K.M. O'Boyle Co-administration of d-amphetamine alters the acute and long-term effects of 3,4- methylenedioxymethamphetamine in rats Br. J. Pharmacol. 131 2000 154
58. E.D. O'Loinsigh, G. Boland, J.P. Kelly, and K.M. O'Boyle Behavioral, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 2001 621 638
59. A.C. Parrott Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research Hum. Psychopharmacol. 16 2001 557 577
60. R. Peltier, and S. Schenk Effects of serotonergic manipulations on cocaine self-administration in rats Psychopharmacology (Berl.) 110 1993 390 394
61. P.V. Piazza, J.M. Deminiere, S. Maccari, P. Mormede, M. Le Moal, and H. Simon Individual reactivity to novelty predicts probability of amphetamine self-administration Behav. Pharmacol. 1 1990 339 345
62. P.V. Piazza, S. Maccari, J.M. Deminiere, M. Le Moal, P. Mormede, and H. Simon Corticosterone levels determine individual vulnerability to amphetamine self-administration Proc. Nat. Acad. Sci. U.S.A. 88 1991 2088 2092
63. P.V. Piazza, F. Rouge-Pont, J.M. Deminiere, M. Kharoubi, M. Le Moal, and H. Simon Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration Brain Res. 567 1991 169 174
64. P.J. Pierre, and P. Vezina Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug Psychopharmacology (Berl.) 129 1997 277 284
65. L.J. Porrino, M.C. Ritz, N.L. Goodman, L.G. Sharpe, M.J. Kuhar, and S.R. Goldberg Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats Life Sci. 45 1989 1529 1535
66. R. Ranaldi, D. Pocock, R. Zereik, and R.A. Wise Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous d-amphetamine self-administration J. Neurosci. 19 1999 4102 4109
67. E. Ratzenboek, A. Sairia, N. Kriechbaum, and G. Nernig Reinforcing effects of MDMA (Ecstasy) in drug-naive and cocaine-treated rats Pharmacology 62 2001 138 144
68. N.R. Richardson, and D.C. Roberts Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat Life Sci. 49 1991 833 840
69. D.C. Roberts, E.A. Loh, G.B. Baker, and G. Vickers Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food Pharmacol. Biochem. Behav. 49 1994 177 182
70. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Brain Res. Rev. 18 1993 247 291
71. T.E. Robinson, and K.C. Berridge The psychology and neurobiology of addiction: an incentive sensitization view Addiction 95 2000 91 117
72. T.E. Robinson, and K.C. Berridge Incentive-sensitization and addiction Addiction 96 2001 103 114
73. R.B. Rothman, and M.H. Baumann Monoamine transporters and psychostimulant drugs Eur. J. Pharmacol. 479 2003 23 40
74. H. Saito, M. Matsumoto, H. Togashi, and M. Yoshioko Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies Jpn. J. Pharmacol. 70 1996 203 205
75. M.D. Schechter Discriminative profile of MDMA Pharmacol. Biochem. Behav. 24 1986 1533 1537
76. M.D. Schechter Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') Pharmacol. Biochem. Behav. 31 1989 817 824
77. M.D. Schechter Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination Pharmacol. Biochem. Behav. 38 1991 539 544
78. M.D. Schechter Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum Pharmacol. Biochem. Behav. 56 1997 89 96
79. M.D. Schechter, and P.G. Cooke Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in the rat Psychopharmacology (Berl.) 42 1975 185 193
80. S. Schenk, D. Gittings, M. Johnstone, and E. Daniela Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats Psychopharmacology (Berl.) 169 2003 21 27
81. C.J. Schmidt, C.K. Black, and V.L. Taylor l-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4- methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats Eur. J. Pharmacol. 203 1991 41 49
82. F.L. Smith, D.S. Yu, D.G. Smith, A.P. Leccese, and W.H. Lyness Dietary tryptophan supplements attenuate amphetamine self-administration in the rat Pharmacol. Biochem. Behav. 25 1986 849 855
83. L.J. Spanos, and B.K. Yamamaoto Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotor and serotonin syndrome behavior in the rat Pharmacol. Biochem. Behav. 4 1989 835 840
84. J.E. Sprague, A.S. Preston, M. Leifheit, and B. Woodside Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning Physiol. Behav. 79 2003 281 287
85. R. Stretch, and G.J. Gerber Drug-induced reinstatement of amphetamine self-administration behavior in monkeys Can. J. Psychol. 27 1973 168 177
86. J.R. Taylor, and T.W. Robbins 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate responding with reward-related stimuli produced intra-accumbens d-amphetamine Psychopharmacology (Berl.) 90 1986 390 397
87. L.T. Tran-Nguyen, D.A. Baker, K.A. Grote, J. Salone, and J.L. Neisewander Serotonin depletion attenuates cocaine-seeking behavior in rats Psychopharmacology (Berl.) 146 1999 60 66
88. L.T. Tran-Nguyen, J.G. Bellow, K.A. Grote, and J.L. Neisewander Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats Psychopharmacology (Berl.) 157 2001 340 348
89. K. von Sydow, R. Lieb, H. Pfister, M. Hofler, and H. Wittchen Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study Drug Alcohol Depend. 66 2002 147 159
90. S.R. White, P. Duffy, and P.W. Kalivas Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo Neuroscience 62 1994 41 50
91. G.S.J. Yacoubian Correlates of Ecstasy use among tenth graders surveyed through monitoring the future J. Psychoactive Drugs 34 2002 225 230